Many people in the UK and elsewhere are currently remembering where they were and what they were doing on the day that Diana Princess of Wales died: August 31st marks 20 years since that fateful day. For Clinical Pharmacologists, we may well remember where we were when we heard the news that six volunteers were […]Read More
Author: Graham Scott
Dr. Scott has more than 30 years’ experience in the pharmaceutical industry, having worked in various roles in pre-clinical, early clinical, and clinical pharmacology drug development. He has varied and deep experience in early clinical development, having led more than 30 FIM studies and "early-in-human" studies. He has interacted with all major health regulatory authorities, having led and overseen multiple filings. His work experience has been with top 20 pharma companies in the UK, US, and mainland Europe. Most recently, Dr. Scott lead Takeda’s European clinical pharmacology team and one of their global clinical pharmacology therapeutic areas. He has completed a leadership program at INSEAD, is a member of the Royal Pharmaceutical Society, and obtained a PhD in Drug Metabolism from the University of Strathclyde.